Prognostic and Predictive Biomarkers in Diffuse Large B cell Lymphoma

por Chan, Alex, Dogan, Ahmet
Publicado en Surg Pathol Clin (2019)

Immunohistochemical Biomarkers in Diagnosis of Hematolymphoid Neoplasms of Endocrine Organs

por Kuzu, Isinsu, Dogan, Ahmet
Publicado en Endocr Pathol (2018)

Fibrinogen alpha amyloidosis: insights from proteomics

por Chapman, Jessica R., Dogan, Ahmet
Publicado en Expert Rev Proteomics (2019)

Identification and targeting of kinase alterations in histiocytic neoplasms

por Ozkaya, Neval, Dogan, Ahmet, Abdel-Wahab, Omar
Publicado en Hematol Oncol Clin North Am (2017)

Mucosa‐associated lymphoid tissue (MALT) lymphoma: a practical guide for pathologists

por Bacon, Chris M, Du, Ming‐Qing, Dogan, Ahmet
Publicado 2007

Leukocyte Cell–Derived Chemotaxin 2–Associated Amyloidosis: A Recently Recognized Disease with Distinct Clinicopathologic Characteristics

por Nasr, Samih H., Dogan, Ahmet, Larsen, Christopher P.
Publicado en Clin J Am Soc Nephrol (2015)

Amyloid and related disorders surgical pathology and clinical correlations /

por Picken, Maria M., Dogan, Ahmet., Herrera, Guillermo A.
Publicado 2012.

EBV-associated lymphoproliferative disorder of CNS associated with the use of mycophenolate mofetil

por O’Neill, Brian Patrick, Vernino, Steven, Dogan, Ahmet, Giannini, Caterina
Publicado 2007

Pharmaceutical amyloidosis associated with subcutaneous insulin and enfuvirtide administration

por D’Souza, Anita, Theis, Jason D., Vrana, Julie A., Dogan, Ahmet
Publicado 2014

Acute Pancreatitis and Gastroduodenal Intussusception Induced by an Underlying Gastric Gastrointestinal Stromal Tumor: A Case Report

por Yildiz, Mehmet Siddik, Doğan, Ahmet, Koparan, Ibrahim Halil, Adin, Mehmet Emin
Publicado en J Gastric Cancer (2016)

Cerebellar EBV-associated diffuse large B cell lymphoma following angioimmunoblastic T cell lymphoma

por Zhou, Yi, Rosenblum, Marc K., Dogan, Ahmet, Jungbluth, Achim A., Chiu, April
Publicado en J Hematop (2015)

Hairy Cell Leukemia Masquerading as CD5+ Lymphoproliferative Disease: The Importance of BRAF V600E Testing in Diagnosis and Treatment

por Soong, Deborah, Kumar, Priyadarshini, Jatwani, Karan, Park, Jae, Dogan, Ahmet, Taylor, Justin
Publicado en JCO Precis Oncol (2021)

Single-Tube 10-Fluorochrome Analysis for Efficient Flow Cytometric Evaluation of Minimal Residual Disease in Plasma Cell Myeloma

por Royston, Daniel J., Gao, Qi, Nguyen, Nghia, Maslak, Peter, Dogan, Ahmet, Roshal, Mikhail
Publicado en Am J Clin Pathol (2016)

B-cell maturation antigen expression across hematologic cancers: a systematic literature review

por Dogan, Ahmet, Siegel, David, Tran, Nguyet, Fu, Alan, Fowler, Jessica, Belani, Rajesh, Landgren, Ola
Publicado en Blood Cancer J (2020)

Strong tranthyretin immunostaining, potential pitfall in cardiac amyloid typing

por Satoskar, Anjali A., Efebera, Yvonne, Hasan, Ayesha, Brodsky, Sergey, Nadasdy, Gyongyi, Dogan, Ahmet, Nadasdy, Tibor
Publicado 2011

Novel iatrogenic amyloidosis caused by peptide drug liraglutide: a clinical mimic of AL amyloidosis

por Martins, Carlo O., Lezcano, Cecilia, Yi, San S., Landau, Heather J., Chapman, Jessica R., Dogan, Ahmet
Publicado en Haematologica (2018)

Inhibition of Syk protein tyrosine kinase induces apoptosis and blocks proliferation in T-cell non-Hodgkin lymphoma cell lines

por Wilcox, Ryan A., Sun, David X., Novak, Anne, Dogan, Ahmet, Ansell, Stephen M., Feldman, Andrew L.
Publicado 2009

Does PRRT with standard activities of (177)Lu-octreotate really achieve relevant somatostatin receptor saturation in target tumor lesions?: insights from intra-therapeutic receptor...

por Sabet, Amir, Nagarajah, James, Dogan, Ahmet Semih, Biersack, Hans-Jürgen, Sabet, Amin, Guhlke, Stefan, Ezziddin, Samer
Publicado 2013

Immune independent crosstalk between lymphoma and myeloid suppressor CD14(+)HLA-DR(low/neg) monocytes mediates chemotherapy resistance

por Zhang, Zhe (Jenny), Bulur, Peggy A, Dogan, Ahmet, Gastineau, Dennis A, Dietz, Allan B, Lin, Yi
Publicado en Oncoimmunology (2015)

Bone marrow fibrosis in chronic myelomonocytic leukemia is associated with increased megakaryopoiesis, splenomegaly and with a shorter median time to disease progression

por Petrova-Drus, Kseniya, Chiu, April, Margolskee, Elizabeth, Barouk-Fox, Sharon, Geyer, Julia, Dogan, Ahmet, Orazi, Attilio
Publicado en Oncotarget (2017)